Peginterferon alfa-2a (40KD) plus ribavirin in chronic hepatitis C patients who failed previous interferon therapy. [electronic resource]
Producer: 20061114Description: 1631-8 p. digitalISSN:- 0017-5749
- Adult
- Antiviral Agents -- adverse effects
- Drug Therapy, Combination
- Female
- Hepatitis C, Chronic -- drug therapy
- Humans
- Interferon alpha-2
- Interferon-alpha -- adverse effects
- Male
- Middle Aged
- Patient Dropouts
- Polyethylene Glycols -- adverse effects
- Recombinant Proteins
- Ribavirin -- adverse effects
- Treatment Failure
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.